News Focus
News Focus
icon url

dstock07734

08/09/24 11:16 AM

#711769 RE: kabunushi #711763

Right now the company can do nothing given the fact the review is underway.

Think about it. What would happen to sp if the most valuable figure from Dr.Liau's present were around? Which type of forces can be powerful enough to let Musella take down the webinar video twice? Dr.Liau's webinar video can still be found on YouTube. But it is shadow banned last time I heard.
icon url

ilovetech

08/09/24 11:25 AM

#711771 RE: kabunushi #711763

Kabunushi - We also have pent up demand coiling like a rumberband. That's why I vacated my Amrn position, because cardiovascular disease, as they say is the "silent killer." GBM on the other hand, causes desperation to find a treatment, as life expectancy is measured in days, and months. There's a good chance final version Eden units have been ordered. It's not a car engine. Prospective partners would not wait until a rollout to get involved. These kinds of deals are planned way in advance. JMHO.
icon url

JFR161162

08/09/24 11:42 AM

#711778 RE: kabunushi #711763

They’ve done > 1,000 compassionate vaccines to patients in the UK since 2014 so manual production is not a concern for the first 1,200 vaccines based of company’s forecast at the beginning after approval.
The key for me is to get to mass production with Eden/Flaskworks asap.
icon url

manibiotech

08/09/24 11:52 AM

#711781 RE: kabunushi #711763

Completely agree
No one wants to hear more phase two , combo trials in pipeline …. Time for that is long gone